Also trades as: NWKHY (OTC) · $vol 0M

R1,725.00 ($1.04)

-16.00 (-0.92%)

Weekly Expected Move ±1.5%

R1690 R1716 R1741 R1766 R1792

JNB · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 38 · R20.5B mcap · 1.17B float · 0.330% daily turnover

Revenue

$26.3B +4.5% ▲

5Y CAGR: +6.9%

Gross Profit

$13.1B +5.1% ▲

5Y CAGR: +7.7%

Operating Income

$3.6B +13.2% ▲

5Y CAGR: +17.9%

Net Income

$1.7B +16.3% ▲

5Y CAGR: +31.3%

EPS (Diluted)

$1.33 +22.0% ▲

5Y CAGR: +36.6%

EBITDA

$5.1B +10.1% ▲

5Y CAGR: +12.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$21.2B	$21.6B	$23.7B	$25.2B	$26.3B
YoY Growth	+12.5%	+2.1%	+9.5%	+6.3%	+4.5%
Cost of Revenue	$10.7B	$11.1B	$11.9B	$12.7B	$13.2B
Gross Profit	$10.5B	$10.6B	$11.8B	$12.5B	$13.1B
Gross Margin	49.3%	48.8%	49.6%	49.4%	49.7%
R&D Expenses	$2M	$2M	$0	$0	$0
SG&A Expenses	$8.5B	$8.6B	$9.4B	$9.6B	$10.0B
Operating Expenses	$8.2B	$8.1B	$9.0B	$9.3B	$9.5B
Operating Income	$2.1B	$2.5B	$2.7B	$3.2B	$3.6B
Operating Margin	9.8%	11.4%	11.5%	12.5%	13.6%
Interest Expense	$844M	$827M	$1.0B	$1.2B	$1.2B
Income Before Tax	$1.2B	$1.5B	$1.8B	$2.1B	$2.5B
Tax Expense	$416M	$484M	$471M	$591M	$713M
Net Income	$769M	$1.0B	$1.3B	$1.5B	$1.7B
Net Margin	3.6%	4.7%	5.3%	5.9%	6.6%
EPS (Diluted)	$0.54	$0.72	$0.94	$1.09	$1.33
EBITDA	$3.2B	$3.5B	$4.1B	$4.6B	$5.1B
Shares Outstanding	1.34B	1.35B	1.34B	1.30B	1.25B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$11.3B	$11.5B	$12.2B	$12.0B	$13.2B	$12.7B	$13.7B	$13.3B
Cost of Revenue	$5.8B	$5.8B	$6.1B	$6.1B	$6.7B	$6.4B	$6.9B	$6.7B
Gross Profit	$5.5B	$5.7B	$6.0B	$6.0B	$6.5B	$6.3B	$6.8B	$6.6B
Gross Margin	48.7%	49.8%	49.4%	49.5%	49.4%	49.9%	49.6%	49.5%
R&D Expenses	$1M	$0	$1M	$0	$0	$0	$0	$0
SG&A Expenses	$4.4B	$4.6B	$4.7B	$4.7B	$5.2B	$5.0B	$5.3B	$5.1B
Operating Expenses	$4.4B	$4.6B	$4.7B	$4.7B	$3.3B	$4.7B	$5.3B	$5.1B
Operating Income	$1.1B	$1.1B	$1.3B	$1.5B	$3.2B	$1.7B	$1.4B	$1.5B
Operating Margin	9.5%	9.9%	10.6%	12.1%	24.0%	13.1%	10.6%	11.1%
Interest Expense	$439M	$472M	$529M	$1.2B	$514M	$507M	$582M	$581M
Income Before Tax	$842M	$919M	$848M	$1.9B	$1.1B	$1.2B	$1.4B	$1.3B
Tax Expense	$258M	$268M	$203M	$562M	$310M	$328M	$385M	$363M
Net Income	$576M	$634M	$673M	$646M	$822M	$786M	$947M	$887M
Net Margin	5.1%	5.5%	5.5%	5.4%	6.2%	6.2%	6.9%	6.7%
EPS (Diluted)	$0.41	$0.46	$0.48	$0.97	$0.59	$0.59	$0.74	$0.70
EBITDA	$1.9B	$2.0B	$2.0B	$4.4B	$2.0B	$2.1B	$2.6B	$2.2B
Shares Outstanding	1.35B	1.34B	1.35B	1.30B	1.30B	1.25B	1.24B	1.20B

NTC.JO JNB